• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c-kit原癌基因在人肝细胞癌中的表达

Expression of c-kit protooncogene in human hepatocellular carcinoma.

作者信息

Chung Chih-Yuan, Yeh Kun-Tu, Hsu Nicholas C, Chang Julia Huei-Mei, Lin Jen-Tsun, Horng Huey-Ching, Chang Cheng-Shyong

机构信息

Division of Hematology-Oncology, Department of Internal Medicine, Changhua Christian Hospital, 135 Nanhsiao Street, Changhua 500, Taiwan, ROC.

出版信息

Cancer Lett. 2005 Jan 20;217(2):231-6. doi: 10.1016/j.canlet.2004.06.045.

DOI:10.1016/j.canlet.2004.06.045
PMID:15617841
Abstract

The expression of the c-kit protooncogene in human hepatocellular carcinoma (HCC) was investigated. Immunohistochemical staining (IHC) and RT-PCR were employed to examine the protein and mRNA expression of c-kit protooncogene, respectively. IHC results demonstrated that 22 of 86 (25.6%) HCC tissue sections expressed c-kit protein. The c-kit mRNA transcript was further confirmed in all 22 IHC c-kit positive HCC tissue samples by RT-PCR. Moreover, the relationship between c-kit expression in HCC and prognosis of patients was statistically analyzed and a correlation was established. The group of patients whose HCC specimens showed positive c-kit staining exhibited better survival as compared to those patients with negative c-kit expression (p=0.021). These results suggest that c-kit expression may be a good prognostic indicator for HCC.

摘要

研究了c-kit原癌基因在人类肝细胞癌(HCC)中的表达情况。分别采用免疫组织化学染色(IHC)和逆转录聚合酶链反应(RT-PCR)检测c-kit原癌基因的蛋白质和mRNA表达。免疫组织化学染色结果显示,86例HCC组织切片中有22例(25.6%)表达c-kit蛋白。通过RT-PCR在所有22例免疫组织化学染色c-kit阳性的HCC组织样本中进一步证实了c-kit mRNA转录本。此外,对HCC中c-kit表达与患者预后的关系进行了统计学分析并建立了相关性。与c-kit表达阴性的患者相比,HCC标本显示c-kit染色阳性的患者组生存期更长(p = 0.021)。这些结果表明,c-kit表达可能是HCC的一个良好预后指标。

相似文献

1
Expression of c-kit protooncogene in human hepatocellular carcinoma.c-kit原癌基因在人肝细胞癌中的表达
Cancer Lett. 2005 Jan 20;217(2):231-6. doi: 10.1016/j.canlet.2004.06.045.
2
Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma.RhoA的过表达与肝细胞癌的不良预后相关。
Eur J Surg Oncol. 2006 Dec;32(10):1130-4. doi: 10.1016/j.ejso.2006.05.012. Epub 2006 Jun 27.
3
Expression of stem cell factor receptor c-kit in human nontumoral and tumoral hepatic cells.干细胞因子受体 c-kit 在人非肿瘤性和肿瘤性肝细胞中的表达。
Eur J Gastroenterol Hepatol. 2009 Oct;21(10):1206-11. doi: 10.1097/MEG.0b013e328317f4ef.
4
Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.核因子-κB受体激活剂配体(RANKL)在伴有骨转移的肝细胞癌中的表达
Ann Surg Oncol. 2007 Mar;14(3):1191-9. doi: 10.1245/s10434-006-9277-4. Epub 2006 Dec 31.
5
[Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].肝细胞生长因子和c-met对肝细胞癌患者的预后价值研究
Zhonghua Wai Ke Za Zhi. 2006 May 1;44(9):603-8.
6
Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.威斯科特-奥尔德里奇综合征蛋白家族维普洛林同源蛋白2表达增加与肝细胞癌预后不良相关。
Clin Cancer Res. 2006 Oct 1;12(19):5673-9. doi: 10.1158/1078-0432.CCR-06-0022.
7
[Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].[硫酸乙酰肝素蛋白聚糖在肝细胞癌微血管中的选择性沉积:发病机制及鉴别诊断方面]
Magy Onkol. 2008 Dec;52(4):379-83. doi: 10.1556/MOnkol.52.2008.4.7.
8
[Expression of liver-type fatty acid-binding protein and vascular endothelial growth factor and their correlation in human hepatocellular carcinoma].肝型脂肪酸结合蛋白与血管内皮生长因子在人肝细胞癌中的表达及其相关性
Nan Fang Yi Ke Da Xue Xue Bao. 2007 Mar;27(3):318-21.
9
Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.生存素mRNA的表达与肝细胞癌中的细胞凋亡、增殖及组织学侵袭性特征相关。
Oncol Rep. 2004 Dec;12(6):1189-94.
10
Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis.肾母细胞瘤1基因在肝细胞癌中表达增加,并与预后不良相关。
Eur J Cancer. 2008 Mar;44(4):600-8. doi: 10.1016/j.ejca.2008.01.008. Epub 2008 Feb 5.

引用本文的文献

1
Integrative network pharmacology and experimental validation reveal emodin derivatives as potential therapeutics for hepatocellular carcinoma.整合网络药理学与实验验证揭示大黄素衍生物为肝细胞癌的潜在治疗药物。
J Egypt Natl Canc Inst. 2025 Jul 21;37(1):52. doi: 10.1186/s43046-025-00306-x.
2
Comparison of Biomarkers Between Hepatic Tumors in Rat Models and a Dog.大鼠模型与犬肝脏肿瘤标志物的比较
In Vivo. 2023 Jan-Feb;37(1):252-261. doi: 10.21873/invivo.13075.
3
C-Kit, a Double-Edged Sword in Liver Regeneration and Diseases.C-Kit:肝脏再生与疾病中的双刃剑
Front Genet. 2021 Feb 2;12:598855. doi: 10.3389/fgene.2021.598855. eCollection 2021.
4
Establishment of a Patient-Derived Xenograft Tumor From Hepatitis C-Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy.建立丙型肝炎相关肝癌患者来源的异种移植肿瘤模型并评估伊马替尼治疗效果。
Hepatology. 2020 Aug;72(2):379-388. doi: 10.1002/hep.31298.
5
Targeted Diphtheria Toxin-Based Therapy: A Review Article.基于靶向白喉毒素的治疗:一篇综述文章。
Front Microbiol. 2019 Oct 18;10:2340. doi: 10.3389/fmicb.2019.02340. eCollection 2019.
6
Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma.确定肝细胞癌总生存期和血管侵犯的一致预后生物标志物。
R Soc Open Sci. 2018 Dec 5;5(12):181006. doi: 10.1098/rsos.181006. eCollection 2018 Dec.
7
Clinical and Prognostic Significances of Cytokeratin 19 and KIT Expression in Surgically Resectable Pancreatic Neuroendocrine Tumors.细胞角蛋白19和KIT表达在可手术切除胰腺神经内分泌肿瘤中的临床及预后意义
J Pathol Transl Med. 2015 Jan;49(1):30-6. doi: 10.4132/jptm.2014.10.23. Epub 2015 Jan 15.
8
Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours.具有抗血管生成和抗增殖活性的新型化合物,用于控制睾丸生殖细胞肿瘤的生长。
Br J Cancer. 2010 Jun 29;103(1):18-28. doi: 10.1038/sj.bjc.6605725. Epub 2010 Jun 15.
9
Moving targets in hepatocellular carcinoma: hepatic progenitor cells as novel targets for tyrosine kinase inhibitors.肝细胞癌中的移动靶标:肝祖细胞作为酪氨酸激酶抑制剂的新靶标
Gastroenterology. 2008 Sep;135(3):733-5. doi: 10.1053/j.gastro.2008.07.036. Epub 2008 Aug 8.
10
Liver cancer stem cells.肝癌干细胞
J Clin Oncol. 2008 Jun 10;26(17):2800-5. doi: 10.1200/JCO.2007.15.5945.